NEA leads Xoc's $30M series A

CNS disease company Xoc Pharmaceuticals Inc. (Los Gatos, Calif.) closed a tranched $30 million series A round led by New Enterprise Associates. Details regarding the round's tranches are not disclosed.

Xoc spokesperson Lisa Borland told BioCentury the company's founders and other private investors also participated in the round...